Literature DB >> 12391346

Phenotypic features of myoclonus-dystonia in three kindreds.

D O Doheny1, M F Brin, C E Morrison, C J Smith, R H Walker, S Abbasi, B Müller, J Garrels, L Liu, P De Carvalho Aguiar, K Schilling, P Kramer, D De Leon, D Raymond, R Saunders-Pullman, C Klein, S B Bressman, B Schmand, M A J Tijssen, L J Ozelius, J M Silverman.   

Abstract

BACKGROUND: Myoclonus-dystonia (M-D) is a movement disorder with involuntary jerks and dystonic contractions. Autosomal dominant alcohol-responsive M-D is associated with mutations in the epsilon-sarcoglycan gene (SGCE) (six families) and with a missense change in the D2 dopamine receptor (DRD2)gene (one family).
OBJECTIVE: To investigate the clinical phenotype associated with M-D including motor symptoms, psychiatric disorders, and neuropsychological deficits.
METHODS: Fifty individuals in three M-D families were evaluated and a standardized neurologic examination and DNA analysis were performed. Psychiatric profiles were established with the Diagnostic Interviews for Genetic Studies (DIGS) and the Yale-Brown Obsessive-Compulsive Scale (YBOCS). Cognition was evaluated with standardized neuropsychological tests.
RESULTS: Distinct truncating mutations in the SGCE gene were identified in each family. Additionally, a missense alteration in the DRD2 gene was previously found in one family. Motor expression was variable, with onset of myoclonus or dystonia or both affecting the upper body and progression to myoclonus and dystonia in most cases. Psychiatric profiles revealed depression, obsessive-compulsive disorder, substance abuse, anxiety/panic/phobic disorders, and psychosis in two families, and depression only in the third family. Averaged scores from cognitive testing showed impaired verbal learning and memory in one family, impaired memory in the second family, and no cognitive deficits in the third family.
CONCLUSIONS: Cognitive deficits may be associated with M-D. Psychiatric abnormalities correlate with the motor symptoms in affected individuals. Assessment of additional M-D families with known mutations is needed to determine whether these are characteristic phenotypic manifestations of M-D.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391346     DOI: 10.1212/wnl.59.8.1187

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Authors:  Susanne Steinlechner; Jessica Stahlberg; Birgit Völkel; Ana Djarmati; Johann Hagenah; Anja Hiller; Katja Hedrich; Inke König; Christine Klein; Rebekka Lencer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-03       Impact factor: 10.154

Review 2.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

3.  Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Guang Yang; Jindong Li; Atbin Doroodchi; Tong Zhou; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-21       Impact factor: 3.332

4.  A point mutation in ε-sarcoglycan induces inherited myoclonus dystonia syndrome in a Chinese family.

Authors:  Hailiang Yan; Xiaoting Guan; Luning Wang; Jiping Tan; Guihong Wang; Yuan An; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2013-04-12

Review 5.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

6.  Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.

Authors:  Lin Zhang; Fumiaki Yokoi; Dee S Parsons; David G Standaert; Yuqing Li
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

7.  SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Authors:  Kathryn J Peall; Daniel J Smith; Manju A Kurian; Mark Wardle; Adrian J Waite; Tammy Hedderly; Jean-Pierre Lin; Martin Smith; Alan Whone; Hardev Pall; Cathy White; Andrew Lux; Philip Jardine; Narinder Bajaj; Bryan Lynch; George Kirov; Sean O'Riordan; Michael Samuel; Timothy Lynch; Mary D King; Patrick F Chinnery; Thomas T Warner; Derek J Blake; Michael J Owen; Huw R Morris
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

8.  SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.

Authors:  Kathryn J Peall; Manju A Kurian; Mark Wardle; Adrian J Waite; Tammy Hedderly; Jean-Pierre Lin; Martin Smith; Alan Whone; Hardev Pall; Cathy White; Andrew Lux; Philip E Jardine; Bryan Lynch; George Kirov; Sean O'Riordan; Michael Samuel; Timothy Lynch; Mary D King; Patrick F Chinnery; Thomas T Warner; Derek J Blake; Michael J Owen; Huw R Morris
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

9.  Sporadic and familial myoclonic dystonia: Report of three cases and review of literature.

Authors:  Kalyan B Bhattacharyya; Arijit Roy; Atanu Biswas; Ashutosh Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

10.  Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus-Dystonia Syndrome.

Authors:  David A Isaacs; Peter Hedera
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.